Ā | measurements | baseline (T0) | 6āweeks (T1) | 3āmonths (T2) | 12āmonths (T3) |
---|---|---|---|---|---|
Demographic | |||||
āage | Ā | x | Ā | Ā | Ā |
āsex | Ā | x | Ā | Ā | Ā |
āeducation | Ā | x | Ā | Ā | Ā |
āmarital status / partner | Ā | x | Ā | Ā | Ā |
āworking status | Ā | x | Ā | Ā | Ā |
āmedical history | Ā | x | Ā | Ā | Ā |
Stroke-related | |||||
āstroke characteristics | type, hemisphere, NIHSS at admission | x | Ā | Ā | Ā |
ālength of hospital admission | Ā | x | Ā | Ā | Ā |
ādisability at discharge | mRS | x | Ā | Ā | Ā |
Screening instruments (intervention group) | |||||
āparticipation | USER-Participation-Ra | Ā | xa | Ā | Ā |
ācognitive and emotional complaints | CLCE-24a | Ā | xa | Ā | Ā |
ācognitive disorders | MoCAa(not for patients in the usual care group) | Ā | xa | Ā | Ā |
āsymptoms of depression and anxiety | HADSa | Ā | xa | Ā | Ā |
āself-efficacy | GSESa | Ā | xĀŖ | Ā | Ā |
Primary outcome | |||||
āparticipation | USER-Participation-Ra | Ā | xa | x | x |
Secondary outcomes | |||||
ācognitive and emotional complaints | CLCE-24a | Ā | xa | x | x |
āsymptoms of depression and anxiety | HADSa | Ā | xa | x | x |
āphysical disability | mRS | x | Ā | x | x |
āself-efficacy | GSESa | Ā | xa | x | x |
āglobal health | PROMIS Global-10 | Ā | x | x | x |
āpatient satisfaction with stroke-care | customized version of SASC-19 | Ā | Ā | x | Ā |
āquality of life | EQ-5D-5L | Ā | x | x | x |
ācost questionnaires | MCQ PCQ | Ā | x | x | x |